FABP4 and cervical cancer: Specifically, in cervical cancer, upregulated FABP4 expression in cancer tissues is associated with poor OS and pelvic lymph node metastasis, indicating the prognostic value of FABP4 in cervical cancer patients (Li et al., 2021).